[1]应桃 吴镜.心肺运动试验在呼吸系统疾病中的应用[J].心血管病学进展,2023,(4):365.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.017]
　YING Tao,WU Jing.Application of Cardiopulmonary exercise testing in respiratory disease[J].Advances in Cardiovascular Diseases,2023,(4):365.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.017]
点击复制

心肺运动试验在呼吸系统疾病中的应用()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年4期
页码:
365
栏目:
综述
出版日期:
2023-04-25

文章信息/Info

Title:
Application of Cardiopulmonary exercise testing in respiratory disease
作者:
应桃 吴镜
(成都市第三人民医院老年科 西南交通大学附属医院,四川 成都 610031)
Author(s):
YING Tao; WU Jing
(Department of GeriatricsThe Thrid Peoples Hospital of Chengdu,The Affiliated Hospital of Southwest Jiaotong University,Chengdu 610031,Sichuan,China)
关键词:
心肺运动试验; 呼吸系统; 应用
Keywords:
Cardiopulmonary exercise testing;  Respiratory system;  Application
DOI:
10.16806/j.cnki.issn.1004-3934.2023.04.017
摘要:
心肺运动试验作为一项新兴的，动态化测量患者心肺功能的评估工具，已在心血管疾病中广泛运用。如今心肺运动试验具有巨大的潜力，在越来越多的非心血管疾病中发挥作用，现就心肺运动试验在呼吸系统疾病中的应用做一综述。
Abstract:
Cardiopulmonary exercise testing has been widely used in cardiovascular disease as an emergingdynamic assessment tool to measure cardiopulmonary function in patients. Nowadays,cardiopulmonary exercise testing has great potential to play a role in an increasing number of non-cardiovascular diseases,and the application of cardiopulmonary exercise testing in respiratory diseases is reviewed

参考文献/References:

[1].Ross RM. ATS/ACCP statement on cardiopulmonary exercise testing[J].,2003,167(2):211-277.
[2].中华医学会心血管病学分会,中国康复医学会心肺预防康复专业委员会,中华心血管病杂志编辑委员会. 心肺运动试验临床规范应用中国专家共识[J]. 中华心血管病杂志,2022,50(10):973-986.
[3].Rabe KF,Hurd S,Anzueto A,et al. Global strategy for the diagnosismanagement,and prevention of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med,2007,176(6):532-555.
[4].Puente-Maestu L,Palange P,Casaburi R,et al. Use of exercise testing in the evaluation of interventional efficacy:an official ERS statement[J]. Eur Respir J,2016,47(2):429-460.
[5].Radtke T,Crook S,Kaltsakas G,et al. ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases[J]. Eur Respir Rev,2019,28(154):180101.
[6].Hiraga T,Maekura R,Okuda Y,et al. Prognostic predictors for survival in patients with COPD using cardiopulmonary exercise testing[J]. Clin Physiol Funct Imaging,2003,23(6):324-331.
[7].Tojo N,Ichioka M,Chida M,et al. Pulmonary exercise testing predicts prognosis in patients with chronic obstructive pulmonary disease[J]. Intern Med.2005,44(1):20-25.
[8].Smith JR,Van Iterson EH,Johnson BD,et al. Exercise ventilatory inefficiency in heart failure and chronic obstructive pulmonary disease[J]. Int J Cardiol,2018,274:232-236.
[9].Cherneva Z,Valev D,Youroukova V,et al. Left ventricular diastolic dysfunction in non-severe chronic obstructive pulmonary disease—A step forward in cardiovascular comorbidome[J]. PLoS One,2021,16(3):e0247940.
[10].Cao M,Chen W. Epidemiology of lung cancer in China[J].Thorac Cancer. 2019;10(1):3-7.
[11].Ha D,Mazzone PJ,Ries AL,et al. The utility of exercise testing in patients with lung cancer[J]. J Thorac Oncol,2016,11(9):1397-1410.
[12].Brunelli A,Kim AW,Berger KI,et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery:diagnosis and management of lung cancer,3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest,2013,143(5 Suppl):e166S-e190S.
[13].Colice GL,Shafazand S,Griffin JP,et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery:ACCP evidenced-based clinical practice guidelines (2nd edition)[J]. Chest,2007,132(3 Suppl):161S-77S.
[14].Guazzi M,Arena R,Halle M,et al. 2016 focused update:clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations[J]. Circulation,2016,133(24):e694-e711.
[15].Licker M,Karenovics W,Diaper J,et al. Short-term preoperative high-intensity interval training in patients awaiting lung cancer surgery:a randomized controlled trial[J]. J Thorac Oncol,2017,12(2):323-333.
[16].Bhatia C,Kayser B. Preoperative high-intensity interval training is effective and safe in deconditioned patients with lung cancer:a randomized clinical trial[J]. J Rehabil Med2019,51(9):712-718.
[17].Karenovics W,Licker M,Ellenberger C,et al. Short-term preoperative exercise therapy does not improve long-term outcome after lung cancer surgery:a randomized controlled study[J]. Eur J Cardiothorac Surg,2017,52(1):47-54.
[18].Fresard I,Licker M,Adler D,et al. Preoperative peak oxygen uptake in lung cancer subjects with neoadjuvant chemotherapy:a cross-sectional study[J]. Respir Care,2016,61(8):1059-1066.
[19].Hebestreit H,Hulzebos EHJ,Schneiderman JE,et al. Cardiopulmonary exercise testing provides additional prognostic information in cystic fibrosis[J]. Am J Respir Crit Care Med,2019,199(8):987-995.
[20].Ulvestad M,Durheim MT,Kongerud JS,et,al. Cardiorespiratory fitness and physical activity following lung transplantation:a national cohort study[J]. Respiration,2020,99(4):316-324.
[21].Saez-Gimenez B,Barrecheguren M,Ramon MA,et al. Near-normal aerobic capacity in long-term survivors after lung transplantation[J]. ERJ Open Res,2021,7(1):00381-2020.
[22].Shi BY,Liu ZJ,Yu T. Development of the organ donation and transplantation system in China[J]. Chin Med J (Engl),2020,133(7):760-765.
[23].Zhao J,Liu D,Huang J,et al. The low utilization rate of donor lungs in China:a single-center experience[J]. Ann Transplant,2021,26:e931409.
[24].Bai C,Chotirmall SH,Rello J,et al. Updated guidance on the management of COVID-19:from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)[J]. Eur Respir Rev,2020,29(157):200287.
[25].Mihalick VL,Canada JM,Arena R,et al. Cardiopulmonary exercise testing during the COVID-19 pandemic[J]. Prog Cardiovasc Dis,2021,67:35-39.
[26].Raman B,Cassar MP,Tunnicliffe EM,et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs,exercise capacity,cognition,quality of life and mental health,post-hospital discharge[J]. EClinicalMedicine,2021,31:100683.
[27].Skj?rten I,Ankerstjerne OAW,Trebinjac D,et al. Cardiopulmonary exercise capacity and limitations 3?months after COVID-19 hospitalisation[J]. Eur Respir J,2021,58(2):2100996.
[28].Cassar MP,Tunnicliffe EM,Petousi N,et al. Symptom persistence despite improvement in cardiopulmonary health—Insights from longitudinal CMR,CPET and lung function testing post-COVID-19[J]. EClinicalMedicine,2021,41:101159.
[29].Vonbank K,Lehmann A,Bernitzky D,et al. Predictors of prolonged cardiopulmonary exercise impairment after COVID-19 infection:a prospective observational study[J]. Front Med(Lausanne),2021,8:773788.
[30].Frésard I,Genecand L,Altarelli M,et al. Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in ’long COVID’ patients with persistent dyspnoea[J]. BMJ Open Respir Res,2022,9(1):e001126.
[31].Aparisi ?,Ybarra-Falcón C,García-Gómez M,et al. Exercise ventilatory inefficiency in post-COVID-19 syndrome:insights from a prospective evaluation[J]. J Clin Med,2021,10(12):2591.
[32].Arena R,Myers J,Kaminsky LA. Cardiopulmonary exercise testing algorithm for viral infection:assessing health risk and short- to long-term effects[J]. J Cardiopulm Rehabil Prev,2021,41(4):E7-E8.
[33].Wilkens H,Lang I,Blankenburg T,et al. Chronic thromboembolic pulmonary hypertension—A position paper[J]. Dtsch Med Wochenschr,2014,139(Suppl 4):S155-S165.
[34].Frost A,Badesch D,Gibbs JSR,et al. Diagnosis of pulmonary hypertension[J]. Eur Respir J,2019,53(1):1801904.
[35].Berry NC,Manyoo A,Oldham WM,et al. Protocol for exercise hemodynamic assessment:performing an invasive cardiopulmonary exercise test in clinical practice[J]. Pulm Circ,2015,5(4):610-618.
[36].Qutrio Baloch Z,Abbas SA,Prasad RM,et al. Potential role of cardiopulmonary exercise testing as an early screening tool for patients with suspected pulmonary hypertension including exercise-induced pulmonary hypertension:results from a retrospective analysis[J]. Perm J,2021,25:20.323.
[37].Gille T,Laveneziana P. Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency[J]. Eur Respir Rev,2021,30(162):200355.
[38].Boutou AK,Daniil Z,Pitsiou G,et al. Cardiopulmonary exercise testing in patients with asthma:What is its clinical value?[J].Respir Med,2020,167:105953.

相似文献/References:

[1]蒋昭隆,刘剑雄.心肺运动试验在心脏瓣膜病的运用现状[J].心血管病学进展,2019,(6):951.[doi:10.16806/j.cnki.issn.1004-3934.201.06.028]
　JIANG Zhaolong,LIU Jianxiong.Application of Cardiopulmonary Exercise Test in Cardiac Valvular Disease[J].Advances in Cardiovascular Diseases,2019,(4):951.[doi:10.16806/j.cnki.issn.1004-3934.201.06.028]
[2]蒋昭隆刘剑雄.心肺运动试验在冠心病运用现状[J].心血管病学进展,2019,(9):1290.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.027]
　JIANG Zhaolong,LIU Jianxiong.Current Status of Cardiopulmonary Exercise Test in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(4):1290.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.027]
[3]张毅 罗勤 赵智慧 赵青 柳志红.心肺运动试验应用于系统性硬化病相关肺动脉高压筛查的研究进展[J].心血管病学进展,2021,(7):577.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.001]
　ZHANG Yi,LUO Qin,ZHAO Zhihui,et al.Cardiopulmonary Exercise Test for Screening of Systemic Sclerosis-Associated Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2021,(4):577.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.001]
[4]谢佳 唐红 徐婷 边叶婷.心肺运动试验在右心疾病中的应用[J].心血管病学进展,2021,(10):873.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.003]
　XIE JiaTANG HongXU TingBIAN Yeting.Application of Cardiopulmonary Exercise Test in Right Heart Disease[J].Advances in Cardiovascular Diseases,2021,(4):873.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.003]
[5]宋燕新 刘萍 赵威.分钟通气量和二氧化碳生成量关系对于心力衰竭患者的价值[J].心血管病学进展,2022,(5):419.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.009]
　SONG Yanxin,LIU Ping,ZHAO Wei.Value of the Relationship of VE and VCO2 in Heart Failure Patients[J].Advances in Cardiovascular Diseases,2022,(4):419.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.009]

更新日期/Last Update: 2023-05-17